首页  > 

The Cardenolide Glycoside Acovenoside A Interferes with Epidermal Growth Factor Receptor Trafficking in Non-Small Cell Lung Cancer Cells

Susanne Hafner, Michael Schmiech, Sophia Johanna Lang

Front Pharmacol (IF:5.6) 2021 May 5;12:611657. doi: 10.3389/fphar.2021.611657.

Drug resistance mechanisms in Japanese anaplastic lymphoma kinase-positive non-small cell lung cancer and the clinical responses based on the resistant mechanisms

Noriko Yanagitani, Ken Uchibori, Sumie Koike, Mika Tsukahara, Satoru Kitazono, Takahiro Yoshizawa, Atsushi Horiike, Fumiyoshi Ohyanagi, Yuichi Tambo, Shingo Nishikawa, Naoya Fujita, Ryohei Katayama, Makoto Nishio

Cancer Sci (IF:5.7) 2020 Mar;111(3):932-939. doi: 10.1111/cas.14314.

Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach

Zhiguang Xiao, Bianca Sperl, Silvia Gärtner, Tatiana Nedelko, Elvira Stacher-Priehse, Axel Ullrich, Pjotr G Knyazev

Oncotarget 2019 Apr 2;10(26):2546-2560. doi: 10.18632/oncotarget.26817.